From the Globe and Mail:
Canadian health authorities will not change their practice of prescribing the anti-viral drug Tamiflu to treat cases of pandemic H1N1 flu in children, despite a new study that raises questions about the drug’s effectiveness.
Researchers at the University of Oxford cautioned about the broad use of anti-viral drugs to treat children 12 years of age and younger suffering from seasonal flu. They found anti-viral drugs have little or no effect on asthma flare-ups, ear infections or bacterial infections in children. Tamiflu was also linked to increased vomiting.
The authors questioned whether children would face the same risks when being treated with anti-virals for the pandemic H1N1 flu virus.
But the Public Health Agency of Canada assured parents Monday that Tamiflu has a strong safety profile, and has recommended doctors prescribe it for infection prevention and to treat cases of H1N1 in infants under one year. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment